15:40 18.01.2012 | ESPI | Zmiana w akcjonariacie (art. 69)
SOPHARMA
Current report 7 buy back 18012012
15:23 16.01.2012 | ESPI | Zmiana w akcjonariacie (art. 69)
SOPHARMA
Current report 6 re insiders transactions
08:51 13.01.2012 | ESPI | Podstawowa działalność operacyjna Grupy (inna niż 11, 15, 19)
SOPHARMA
Current report 5 on exceeding 5% in the capital of Hydroizomat AD 13012012
14:55 09.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Current report re insiders transactions 5
14:30 06.01.2012 | ESPI | Zmiana w akcjonariacie (art. 69)
SOPHARMA
Zakup akcji własnych
14:09 06.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Current report 3 re insiders transactions
14:23 05.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Correction current report 2 re 2011 results
14:22 05.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Correction current report 2 re 2011 results
13:37 05.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Current report 2 re 2011 results
09:22 05.01.2012 | ESPI | Komunikat w języku obcym
SOPHARMA
Current report re insider transactions
12:51 15.12.2011 | ESPI
SOPHARMA
Report on buy-back of shares
11:34 12.12.2011 | EBI
SOPHARMA
INITIAL REPORT ON CORPORATE GOVERNANCE
17:33 05.12.2011 | ESPI
SOPHARMA
NOTIFICATION OF INSIDER’S TRANSACTIONS
16:46 05.12.2011 | ESPI
SOPHARMA
RESULTS FOR NOVEMBER 2011
16:35 05.12.2011 | ESPI
SOPHARMA
SHAREHOLDERS REPRESENTING MORE THAN FIVE PERCENT OF THE VOTES AT THE EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS HELD ON 30 NOVEMBER 2011
16:17 02.12.2011 | ESPI
SOPHARMA
MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
17:19 29.11.2011 | ESPI | Raporty okresowe: kwartalne, półroczne, roczne
SOPHARMA
PUBLICATION OF THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE NINE-MONTH PERIOD ENDED 30 SEPTEMBER 2011
16:31 25.11.2011 | ESPI
SOPHARMA
THE INTRODUCTION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WARSAW STOCK EXCHANGE
19:23 24.11.2011 | ESPI
SOPHARMA
ADMISSION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WSE
19:16 24.11.2011 | ESPI
SOPHARMA
ACCESS TO THE ESPI SYSTEM